Recce Pharmaceuticals Ltd (RCE) - Total Liabilities

Latest as of June 2026: AU$25.25 Million AUD ≈ $17.87 Million USD

Based on the latest financial reports, Recce Pharmaceuticals Ltd (RCE) has total liabilities worth AU$25.25 Million AUD (≈ $17.87 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check RCE cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Recce Pharmaceuticals Ltd - Total Liabilities Trend (2013–2026)

This chart illustrates how Recce Pharmaceuticals Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see RCE current and non-current assets.

Recce Pharmaceuticals Ltd Competitors by Total Liabilities

The table below lists competitors of Recce Pharmaceuticals Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Gateway Real Estate AG XETRA:GTY	Germany	€1.18 Billion
FALCON METALS LTD F:E47	Germany	€883.21K
Best Agrolife Limited NSE:BESTAGRO	India	Rs11.54 Billion
Samchem Holdings Bhd KLSE:5147	Malaysia	RM303.92 Million
Fortune Minerals Limited TO:FT	Canada	CA$15.13 Million
Shalimar Paints Limited NSE:SHALPAINTS	India	Rs4.03 Billion
Cayman Engley Industrial Co TW:2239	Taiwan	NT$16.72 Billion
Comet Ridge Ltd AU:COI	Australia	AU$47.06 Million

Liability Composition Analysis (2013–2026)

This chart breaks down Recce Pharmaceuticals Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Recce Pharmaceuticals Ltd (RCE) balance sheet quality index to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.44	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-1.51	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	2.96	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Recce Pharmaceuticals Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Recce Pharmaceuticals Ltd (2013–2026)

The table below shows the annual total liabilities of Recce Pharmaceuticals Ltd from 2013 to 2026.

Year	Total Liabilities	Change
2026-06-30	AU$25.25 Million ≈ $17.87 Million	+63.26%
2025-06-30	AU$15.47 Million ≈ $10.94 Million	-2.69%
2024-06-30	AU$15.89 Million ≈ $11.25 Million	+208.93%
2023-06-30	AU$5.14 Million ≈ $3.64 Million	+100.79%
2022-06-30	AU$2.56 Million ≈ $1.81 Million	+117.54%
2021-06-30	AU$1.18 Million ≈ $833.38K	+26.44%
2020-06-30	AU$931.53K ≈ $659.11K	-29.84%
2019-06-30	AU$1.33 Million ≈ $939.49K	+195.84%
2018-06-30	AU$448.82K ≈ $317.57K	-48.67%
2017-06-30	AU$874.44K ≈ $618.72K	+322.85%
2016-06-30	AU$206.80K ≈ $146.32K	-24.10%
2015-06-30	AU$272.47K ≈ $192.79K	+33.69%
2014-06-30	AU$203.81K ≈ $144.21K	+31.86%
2013-06-30	AU$154.57K ≈ $109.37K	--

About Recce Pharmaceuticals Ltd

AU:RCE Australia Biotechnology

Market Cap

$70.31 Million

AU$99.38 Million AUD

Market Cap Rank

#20684 Global

#697 in Australia

Share Price

AU$0.33

Change (1 day)

-4.41%

52-Week Range

AU$0.32 - AU$0.71

All Time High

AU$1.68